Global Mesalazine Market Insights and Forecast to 2028

Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
Market Analysis and Insights: Global Mesalazine Market
Due to the COVID-19 pandemic, the global Mesalazine market size is estimated to be worth US$ 155.1 million in 2022 and is forecast to a readjusted size of US$ 197.4 million by 2028 with a CAGR of 4.1% during the review period. Fully considering the economic change by this health crisis, Purity ≥ 97 % accounting for % of the Mesalazine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Tablets segment is altered to an % CAGR throughout this forecast period.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories and Cambrex Corporation, which accounted for 24.07%, 12.91% and 6.61% of revenues in 2019, respectively. In terms of regions, the revenue share in Europe is the highest, reaching 46.73% in 2019.
Global Mesalazine Scope and Segment
Mesalazine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Mesalazine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
By Company
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE